COPD

Reading File
The query is broad - "COPD" alone could mean many things. Let me clarify before diving in.
Asking for Preferences
Searching sources...
Finding Sources
Searching PubMed

"COPD" AND "pathophysiology"

Finding Sources
Reading File
That block covers PH in COPD. Let me go to the main COPD definition/pathophysiology sections from Murray & Nadel and Fishman's.
Finding Sources
Reading File
Let me search for the core COPD chapters directly.
Finding Sources
Finding Sources
Good - found several key sources. Let me read the most comprehensive ones: the Murray & Nadel main COPD chapter and the Robbins pathology section.
Reading File
Reading File
Excellent content from Robbins. Now let me read more of the pathophysiology section and fetch the key images.
Reading File
Loading Image
Good content. Let me fetch the pathogenesis diagram and read more of this section.
Loading Image
Reading File
I now have enough from Robbins pathology (covering emphysema, chronic bronchitis, pathogenesis). Let me also get the clinical features and read the section continuing from the emphysema pathogenesis text, plus the Murray & Nadel block2 entry which appears to be a core COPD section.
Reading File
Reading File
I now have all the key content needed. Let me also quickly read the chronic bronchitis morphology and COPD clinical features from Robbins.
Reading File
I now have comprehensive content. Let me compile the full answer.

Chronic Obstructive Pulmonary Disease (COPD): Overview & Pathophysiology

Definition

The WHO defines COPD as "a common, preventable and treatable disease characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities caused by exposure to noxious particles or gases." The airflow limitation is largely irreversible, distinguishing it from asthma.
The GOLD (Global Initiative for Chronic Obstructive Lung Disease) criteria confirm diagnosis with spirometry: a post-bronchodilator FEV1/FVC ratio < 0.70.
COPD is an umbrella term that encompasses two major overlapping patterns of lung injury:
Overlap between COPD components
Fig. 11.4 - Schematic showing overlap between emphysema, chronic bronchitis, and asthma. (Robbins & Kumar Basic Pathology)

Epidemiology & Risk Factors

  • Affects >10% of U.S. adults over age 40; the 3rd leading cause of death worldwide
  • Smoking accounts for ~80% of all cases; 35-50% of heavy smokers develop COPD
  • Women appear more susceptible than men
  • Other risk factors:
    • Poor lung development in early life
    • Environmental/occupational pollutants (sulfur dioxide, nitrogen dioxide, dust)
    • Airway hyperresponsiveness
    • Genetic: α1-antitrypsin (AAT) deficiency (~1% of emphysema cases)
    • Respiratory infections in childhood
  • Robbins & Kumar Basic Pathology, p. 447

Component Diseases

1. Emphysema

Emphysema is defined anatomically as permanent enlargement of air spaces distal to the terminal bronchioles, with destruction of alveolar walls but without significant fibrosis.

Four Patterns:

PatternLocationAssociation
Centriacinar (centrilobular)Central/proximal acinus; upper lobesCigarette smoking (most common, ~20x more frequent than panacinar)
Panacinar (panlobular)Entire acinus uniformly; lower lobesα1-antitrypsin deficiency
Distal acinar (paraseptal)Distal acinus, near pleuraYoung adults; spontaneous pneumothorax
IrregularIrregular involvementScarring; usually clinically insignificant
Morphology: Pale, voluminous lungs; histology shows destroyed alveolar walls without fibrosis and enlarged air spaces. Alveolar capillaries are diminished. Terminal and respiratory bronchioles deform due to loss of anchoring septa.
  • Robbins & Kumar Basic Pathology, pp. 447-449

2. Chronic Bronchitis

Defined clinically (not anatomically) as a productive cough for at least 3 consecutive months in at least 2 consecutive years, in the absence of other explanations.
Key pathological feature: Hypersecretion of mucus from enlarged submucosal glands.
Reid Index: Ratio of mucous gland thickness to bronchial wall thickness. Normal ≤0.4. Raised (>0.4) in chronic bronchitis.
Morphology:
  • Hypertrophy of mucous glands in trachea and large bronchi
  • Goblet cell metaplasia in smaller bronchi and bronchioles
  • Inflammatory infiltrate: macrophages, neutrophils, lymphocytes (notably no eosinophils, unlike asthma)
  • Small airway disease (chronic bronchiolitis): mucous plugging, inflammation, submucosal fibrosis → luminal narrowing → airflow obstruction
  • Robbins & Kumar Basic Pathology, p. 449

Pathogenesis

Pathogenesis of Emphysema
Fig. 11.6 - Pathogenesis of emphysema. (Robbins & Kumar Basic Pathology)
Three central mechanisms drive alveolar destruction:

1. Inflammatory Cells & Mediators

Cigarette smoke and noxious particles trigger innate and adaptive immune responses. Key mediators include:
  • Leukotriene B4 and IL-8 (chemotactic for neutrophils)
  • TNF-α and other proinflammatory cytokines
  • Recruited cells: neutrophils, macrophages, CD4+ and CD8+ T cells
  • Lymphoid follicles are increasingly recognized as central to COPD pathogenesis; lymphatic vessel density increases around alveolar spaces and correlates with disease severity

2. Protease-Antiprotease Imbalance

This is the cornerstone mechanism:
  • Inflammatory cells release elastase and other proteases (matrix metalloproteinases) that degrade elastin and other extracellular matrix proteins
  • Normally countered by α1-antitrypsin (AAT) - encoded at the Pi locus on chromosome 14
  • Pi ZZ genotype (homozygous Z allele, ~0.01% of U.S. population): markedly reduced AAT → panacinar emphysema at an earlier age, worsened by smoking
  • Loss of alveolar elastic tissue reduces radial traction on respiratory bronchioles → dynamic airway collapse during expiration → functional airflow obstruction even without mechanical blockage

3. Oxidative Stress

  • Reactive oxygen species (ROS) in cigarette smoke cause direct tissue damage
  • ROS also stimulate macrophages and neutrophils to release more ROS (amplification loop)
  • Oxidative stress drives increased apoptosis and cellular senescence of structural lung cells

Airway Infection

  • Not involved in disease initiation
  • Bacterial/viral infections trigger acute exacerbations by sustaining inflammation
  • Robbins & Kumar Basic Pathology, pp. 447-449

Mechanisms of Airflow Obstruction

COPD causes obstruction through two main mechanisms:
MechanismComponent
Loss of alveolar elastic recoil (radial traction) → dynamic collapse of small airways on expirationEmphysema
Airway narrowing due to mucous plugging, goblet cell metaplasia, inflammation, and submucosal fibrosisChronic bronchitis / small airway disease

Functional Consequences

  • Spirometry: Reduced FEV1, normal or near-normal FVC → reduced FEV1/FVC ratio (< 0.70)
  • Air trapping → hyperinflation → barrel chest, flattened diaphragm on imaging
  • Ventilation-perfusion (V/Q) mismatch → hypoxemia
  • In advanced disease: hypercapnia (hypoventilation)
  • Chronic hypoxemia → pulmonary vasoconstrictionpulmonary hypertension → cor pulmonale
  • Mild PH is common in stable COPD; severe PH (mPAP ≥ 40 mmHg) is rare (~1-3%)

Classic Clinical Phenotypes

Feature"Pink Puffer" (Emphysema dominant)"Blue Bloater" (Chronic bronchitis dominant)
BuildThin, cachecticOverweight
CoughMinimalProductive, chronic
DyspneaProminentLess prominent early
Gas exchangeRelatively preserved until lateHypoxemia + hypercapnia
CyanosisAbsentPresent
Cor pulmonaleLateEarlier
OSA riskLower (lower BMI, hyperinflation)Higher (higher BMI, lower respiratory drive)
  • Murray & Nadel's Textbook of Respiratory Medicine, p. 2747

Key Comorbidities & Systemic Effects

  • OSA-COPD Overlap Syndrome: ~1% of general population; at higher risk for hypercapnia, PH, and COPD exacerbations. CPAP improves survival and reduces hospitalizations in overlap patients.
  • Weight loss / cachexia: Common; can mimic occult malignancy
  • Pulmonary hypertension: Primarily due to hypoxic vasoconstriction
  • Right heart failure (Cor pulmonale)
  • Sleep-related hypoventilation: REM sleep causes accessory muscle paralysis, worsening hypoxemia and hypercapnia in advanced COPD

Sources:
  • Robbins & Kumar Basic Pathology, pp. 447-450
  • Murray & Nadel's Textbook of Respiratory Medicine (2-Volume), pp. 179, 2747
  • Fishman's Pulmonary Diseases and Disorders (2-Volume Set)
This is a shared conversation. Sign in to Orris to start your own chat.